APO Research
Talk to an analyst

APO RESEARCH · REPORT

3D Microfluidic Organ Chip

3D Microfluidic Organ Chip refers to microfluidic devices or research substrates for the named small-volume workflow.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Geometry, material, channels, fluid interface and analytical purpose define the device; a research platform differs from an implant or treatment.

What turns activity into demand

Define the purchased configuration, installation or application interfaces and acceptance requirements. Initial equipment purchases, replacements, consumables and related services need separate commercial boundaries.

The commercial boundary

Use the selected edition’s product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless the edition explicitly combines them.

Which supplied scope and interfaces define 3D Microfluidic Organ Chip?

Geometry, material, channels, fluid interface and analytical purpose define the device; a research platform differs from an implant or treatment.

Selected research

Market Structure

Global 3D Microfluidic Organ Chip Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 January 2026196 pages

Choose your research edition.

Industry Research3D Microfluidic Organ Chip Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal 3D Microfluidic Organ Chip Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal 3D Microfluidic Organ Chip Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 3D Microfluidic Organ Chip Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal 3D Microfluidic Organ Chip Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global 3D Microfluidic Organ Chip market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for 3D Microfluidic Organ Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 3D Microfluidic Organ Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 3D Microfluidic Organ Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for 3D Microfluidic Organ Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 3D Microfluidic Organ Chip include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis and Micronit Microtechnologies B.V., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines 3D Microfluidic Organ Chip output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of 3D Microfluidic Organ Chip by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global 3D Microfluidic Organ Chip market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 3D Microfluidic Organ Chip and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 3D Microfluidic Organ Chip sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 3D Microfluidic Organ Chip market size, projected growth trends, production technologies, key applications, and end-use industries.

3D Microfluidic Organ Chip Segment by Company

Emulate

TissUse

Hesperos

CN Bio Innovations

Tara Biosystems

Draper Laboratory

Mimetas

Nortis

Micronit Microtechnologies B.V.

Kirkstall

Cherry Biotech SAS

Else Kooi Laboratory

3D Microfluidic Organ Chip Segment by Type

Brain-on-a-chip

Liver-on-a-chip

Kidney-on-a-chip

Others

3D Microfluidic Organ Chip Segment by Application

Hospital

Biotechnology

Others

3D Microfluidic Organ Chip Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 3D Microfluidic Organ Chip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 3D Microfluidic Organ Chip and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 3D Microfluidic Organ Chip.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 3D Microfluidic Organ Chip market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 3D Microfluidic Organ Chip industry.

Chapter 3: Detailed analysis of 3D Microfluidic Organ Chip market competition landscape. Including 3D Microfluidic Organ Chip manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of 3D Microfluidic Organ Chip by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of 3D Microfluidic Organ Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. 3D Microfluidic Organ Chip Industry Trends Table 2. 3D Microfluidic Organ Chip Industry Drivers Table 3. 3D Microfluidic Organ Chip Industry Opportunities and Challenges Table 4. 3D Microfluidic Organ Chip Industry Restraints Table 5. Global 3D Microfluidic Organ Chip Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global 3D Microfluidic Organ Chip Production Value Share by Manufacturers (2021-2026) Table 7. Global 3D Microfluidic Organ Chip Production by Manufacturers (k units) & (2021-2026) Table 8. Global 3D Microfluidic Organ Chip Production Market Share by Manufacturers Table 9. Global 3D Microfluidic Organ Chip Average Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global 3D Microfluidic Organ Chip Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global 3D Microfluidic Organ Chip Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global 3D Microfluidic Organ Chip Manufacturers, Product Type & Application Table 13. Global 3D Microfluidic Organ Chip Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global 3D Microfluidic Organ Chip by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Brain-on-a-chip Table 17. Major Manufacturers of Liver-on-a-chip Table 18. Major Manufacturers of Kidney-on-a-chip Table 19. Major Manufacturers of Others Table 20. Global 3D Microfluidic Organ Chip Production by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global 3D Microfluidic Organ Chip Production by Type (2021-2026) & (k units) Table 22. Global 3D Microfluidic Organ Chip Production by Type (2027-2032) & (k units) Table 23. Global 3D Microfluidic Organ Chip Production Market Share by Type (2021-2026) Table 24. Global 3D Microfluidic Organ Chip Production Market Share by Type (2027-2032) Table 25. Global 3D Microfluidic Organ Chip Production Value by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global 3D Microfluidic Organ Chip Production Value by Type (2021-2026) & (k units) Table 27. Global 3D Microfluidic Organ Chip Production Value by Type (2027-2032) & (k units) Table 28. Global 3D Microfluidic Organ Chip Production Value Market Share by Type (2021-2026) Table 29. Global 3D Microfluidic Organ Chip Production Value Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Biotechnology Table 32. Major Manufacturers of Others Table 33. Global 3D Microfluidic Organ Chip Production by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global 3D Microfluidic Organ Chip Production by Application (2021-2026) & (k units) Table 35. Global 3D Microfluidic Organ Chip Production by Application (2027-2032) & (k units) Table 36. Global 3D Microfluidic Organ Chip Production Market Share by Application (2021-2026) Table 37. Global 3D Microfluidic Organ Chip Production Market Share by Application (2027-2032) Table 38. Global 3D Microfluidic Organ Chip Production Value by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global 3D Microfluidic Organ Chip Production Value by Application (2021-2026) & (k units) Table 40. Global 3D Microfluidic Organ Chip Production Value by Application (2027-2032) & (k units) Table 41. Global 3D Microfluidic Organ Chip Production Value Market Share by Application (2021-2026) Table 42. Global 3D Microfluidic Organ Chip Production Value Market Share by Application (2027-2032) Table 43. Emulate Company Information Table 44. Emulate Business Overview Table 45. Emulate 3D Microfluidic Organ Chip Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Emulate 3D Microfluidic Organ Chip Product Portfolio Table 47. Emulate Recent Development Table 48. TissUse Company Information Table 49. TissUse Business Overview Table 50. TissUse 3D Microfluidic Organ Chip Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. TissUse 3D Microfluidic Organ Chip Product Portfolio Table 52. TissUse Recent Development Table 53. Hesperos Company Information Table 54. Hesperos Business Overview Table 55. Hesperos 3D Microfluidic Organ Chip Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Hesperos 3D Microfluidic Organ Chip Product Portfolio Table 57. Hesperos Recent Development Table 58. CN Bio Innovations Company Information Table 59. CN Bio Innovations Business Overview Table 60. CN Bio Innovations 3D Microfluidic Organ Chip Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. CN Bio Innovations 3D Microfluidic Organ Chip Product Portfolio Table 62. CN Bio Innovations Recent Development Table 63. Tara Biosystems Company Information Table 64. Tara Biosystems Business Overview Table 65. Tara Biosystems 3D Microfluidic Organ Chip Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Tara Biosystems 3D Microfluidic Organ Chip Product Portfolio Table 67. Tara Biosystems Recent Development Table 68. Draper Laboratory Company Information Table 69. Draper Laboratory Business Overview Table 70. Draper Laboratory 3D Microfluidic Organ Chip Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Draper Laboratory 3D Microfluidic Organ Chip Product Portfolio Table 72. Draper Laboratory Recent Development Table 73. Mimetas Company Information Table 74. Mimetas Business Overview Table 75. Mimetas 3D Microfluidic Organ Chip Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Mimetas 3D Microfluidic Organ Chip Product Portfolio Table 77. Mimetas Recent Development Table 78. Nortis Company Information Table 79. Nortis Business Overview Table 80. Nortis 3D Microfluidic Organ Chip Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Nortis 3D Microfluidic Organ Chip Product Portfolio Table 82. Nortis Recent Development Table 83. Micronit Microtechnologies B.V. Company Information Table 84. Micronit Microtechnologies B.V. Business Overview Table 85. Micronit Microtechnologies B.V. 3D Microfluidic Organ Chip Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Micronit Microtechnologies B.V. 3D Microfluidic Organ Chip Product Portfolio Table 87. Micronit Microtechnologies B.V. Recent Development Table 88. Kirkstall Company Information Table 89. Kirkstall Business Overview Table 90. Kirkstall 3D Microfluidic Organ Chip Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Kirkstall 3D Microfluidic Organ Chip Product Portfolio Table 92. Kirkstall Recent Development Table 93. Cherry Biotech SAS Company Information Table 94. Cherry Biotech SAS Business Overview Table 95. Cherry Biotech SAS 3D Microfluidic Organ Chip Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Cherry Biotech SAS 3D Microfluidic Organ Chip Product Portfolio Table 97. Cherry Biotech SAS Recent Development Table 98. Else Kooi Laboratory Company Information Table 99. Else Kooi Laboratory Business Overview Table 100. Else Kooi Laboratory 3D Microfluidic Organ Chip Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Else Kooi Laboratory 3D Microfluidic Organ Chip Product Portfolio Table 102. Else Kooi Laboratory Recent Development Table 103. Global 3D Microfluidic Organ Chip Production by Region: 2021 VS 2025 VS 2032 (k units) Table 104. Global 3D Microfluidic Organ Chip Production by Region (2021-2026) & (k units) Table 105. Global 3D Microfluidic Organ Chip Production Market Share by Region (2021-2026) Table 106. Global 3D Microfluidic Organ Chip Production Forecast by Region (2027-2032) & (k units) Table 107. Global 3D Microfluidic Organ Chip Production Market Share Forecast by Region (2027-2032) Table 108. Global 3D Microfluidic Organ Chip Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 109. Global 3D Microfluidic Organ Chip Production Value by Region (2021-2026) & (US$ Million) Table 110. Global 3D Microfluidic Organ Chip Production Value Share by Region (2021-2026) Table 111. Global 3D Microfluidic Organ Chip Production Value by Region (2027-2032) & (US$ Million) Table 112. Global 3D Microfluidic Organ Chip Production Value Share by Region: (2027-2032) & (US$ Million) Table 113. Global 3D Microfluidic Organ Chip Market Average Price (USD/unit) by Region (2021-2026) Table 114. Global 3D Microfluidic Organ Chip Market Average Price (USD/unit) by Region (2027-2032) Table 115. Global 3D Microfluidic Organ Chip Consumption by Region: 2021 VS 2025 VS 2032 (k units) Table 116. Global 3D Microfluidic Organ Chip Consumption by Region (2021-2026) & (k units) Table 117. Global 3D Microfluidic Organ Chip Consumption Market Share by Region (2021-2026) Table 118. Global 3D Microfluidic Organ Chip Consumption Forecasted by Region (2027-2032) & (k units) Table 119. Global 3D Microfluidic Organ Chip Consumption Forecasted Market Share by Region (2027-2032) Table 120. North America 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 121. North America 3D Microfluidic Organ Chip Consumption by Country (2021-2026) & (k units) Table 122. North America 3D Microfluidic Organ Chip Consumption by Country (2027-2032) & (k units) Table 123. Europe 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 124. Europe 3D Microfluidic Organ Chip Consumption by Country (2021-2026) & (k units) Table 125. Europe 3D Microfluidic Organ Chip Consumption by Country (2027-2032) & (k units) Table 126. Asia Pacific 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 127. Asia Pacific 3D Microfluidic Organ Chip Consumption by Country (2021-2026) & (k units) Table 128. Asia Pacific 3D Microfluidic Organ Chip Consumption by Country (2027-2032) & (k units) Table 129. South America 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 130. South America 3D Microfluidic Organ Chip Consumption by Country (2021-2026) & (k units) Table 131. South America 3D Microfluidic Organ Chip Consumption by Country (2027-2032) & (k units) Table 132. Middle East & Africa 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 133. Middle East & Africa 3D Microfluidic Organ Chip Consumption by Country (2021-2026) & (k units) Table 134. Middle East & Africa 3D Microfluidic Organ Chip Consumption by Country (2027-2032) & (k units) Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. 3D Microfluidic Organ Chip Distributors List Table 138. 3D Microfluidic Organ Chip Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. 3D Microfluidic Organ Chip Product Image Figure 2. Global 3D Microfluidic Organ Chip Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 3D Microfluidic Organ Chip Production Value (2021-2032) & (US$ Million) Figure 4. Global 3D Microfluidic Organ Chip Production Capacity (2021-2032) & (k units) Figure 5. Global 3D Microfluidic Organ Chip Production (2021-2032) & (k units) Figure 6. Global 3D Microfluidic Organ Chip Average Price (USD/unit) & (2021-2032) Figure 7. Global Top 5 and 10 3D Microfluidic Organ Chip Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Brain-on-a-chip Image Figure 10. Liver-on-a-chip Image Figure 11. Kidney-on-a-chip Image Figure 12. Others Image Figure 13. Global 3D Microfluidic Organ Chip Production by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global 3D Microfluidic Organ Chip Production Market Share 2021 VS 2025 VS 2032 Figure 15. Global 3D Microfluidic Organ Chip Production Market Share by Type (2021-2032) Figure 16. Global 3D Microfluidic Organ Chip Production Value by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global 3D Microfluidic Organ Chip Production Value Share 2021 VS 2025 VS 2032 Figure 18. Global 3D Microfluidic Organ Chip Production Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Biotechnology Image Figure 21. Others Image Figure 22. Global 3D Microfluidic Organ Chip Production by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global 3D Microfluidic Organ Chip Production Market Share 2021 VS 2025 VS 2032 Figure 24. Global 3D Microfluidic Organ Chip Production Market Share by Application (2021-2032) Figure 25. Global 3D Microfluidic Organ Chip Production Value by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global 3D Microfluidic Organ Chip Production Value Share 2021 VS 2025 VS 2032 Figure 27. Global 3D Microfluidic Organ Chip Production Value Share by Application (2021-2032) Figure 28. Global 3D Microfluidic Organ Chip Production by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global 3D Microfluidic Organ Chip Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global 3D Microfluidic Organ Chip Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global 3D Microfluidic Organ Chip Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America 3D Microfluidic Organ Chip Production Value (2021-2032) & (US$ Million) Figure 33. Europe 3D Microfluidic Organ Chip Production Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific 3D Microfluidic Organ Chip Production Value (2021-2032) & (US$ Million) Figure 35. South America 3D Microfluidic Organ Chip Production Value (2021-2032) & (US$ Million) Figure 36. Middle East & Africa 3D Microfluidic Organ Chip Production Value (2021-2032) & (US$ Million) Figure 37. North America 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 38. North America 3D Microfluidic Organ Chip Consumption Market Share by Country (2021-2032) Figure 39. U.S. 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 40. Canada 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 41. Mexico 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 42. Europe 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 43. Europe 3D Microfluidic Organ Chip Consumption Market Share by Country (2021-2032) Figure 44. Germany 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 45. France 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 46. U.K. 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 47. Italy 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 48. Netherlands 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 49. Asia Pacific 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 50. Asia Pacific 3D Microfluidic Organ Chip Consumption Market Share by Country (2021-2032) Figure 51. China 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 52. Japan 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 53. South Korea 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 54. Southeast Asia 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 55. India 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 56. Australia 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 57. South America 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 58. South America 3D Microfluidic Organ Chip Consumption Market Share by Country (2021-2032) Figure 59. Brazil 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 60. Argentina 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 61. Chile 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 62. Middle East & Africa 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 63. Middle East & Africa 3D Microfluidic Organ Chip Consumption Market Share by Country (2021-2032) Figure 64. Egypt 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 65. South Africa 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 66. Israel 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 67. Türkiye 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 68. GCC Countries 3D Microfluidic Organ Chip Consumption and Growth Rate (2021-2032) & (k units) Figure 69. 3D Microfluidic Organ Chip Value Chain Figure 70. Manufacturing Cost Structure Figure 71. 3D Microfluidic Organ Chip Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Brain-on-a-chip
  • Liver-on-a-chip
  • Kidney-on-a-chip
  • Others
Applications
  • Hospital
  • Biotechnology
  • Others
Companies covered
  • Emulate
  • TissUse
  • Hesperos
  • CN Bio Innovations
  • Tara Biosystems
  • Draper Laboratory
  • Mimetas
  • Nortis
  • Micronit Microtechnologies B.V.
  • Kirkstall
  • Cherry Biotech SAS
  • Else Kooi Laboratory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global 3D Microfluidic Organ Chip Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global 3D Microfluidic Organ Chip Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global 3D Microfluidic Organ Chip Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global 3D Microfluidic Organ Chip Market Dynamics
  1. 2.1 3D Microfluidic Organ Chip Industry Trends
  2. 2.2 3D Microfluidic Organ Chip Industry Drivers
  3. 2.3 3D Microfluidic Organ Chip Industry Opportunities and Challenges
  4. 2.4 3D Microfluidic Organ Chip Industry Restraints
3 3D Microfluidic Organ Chip Market by Manufacturers
  1. 3.1 Global 3D Microfluidic Organ Chip Production Value by Manufacturers (2021-2026)
  2. 3.2 Global 3D Microfluidic Organ Chip Production by Manufacturers (2021-2026)
  3. 3.3 Global 3D Microfluidic Organ Chip Average Price by Manufacturers (2021-2026)
  4. 3.4 Global 3D Microfluidic Organ Chip Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 3D Microfluidic Organ Chip Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global 3D Microfluidic Organ Chip Manufacturers, Product Type & Application
  7. 3.7 Global 3D Microfluidic Organ Chip Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 3D Microfluidic Organ Chip Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 3D Microfluidic Organ Chip Players Market Share by Production Value in 2025
  11. 3.8.3 2025 3D Microfluidic Organ Chip Tier 1, Tier 2, and Tier 3
4 3D Microfluidic Organ Chip Market by Type
  1. 4.1 3D Microfluidic Organ Chip Type Introduction
  2. 4.1.1 Brain-on-a-chip
  3. 4.1.2 Liver-on-a-chip
  4. 4.1.3 Kidney-on-a-chip
  5. 4.1.4 Others
  6. 4.2 Global 3D Microfluidic Organ Chip Production by Type
  7. 4.2.1 Global 3D Microfluidic Organ Chip Production by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global 3D Microfluidic Organ Chip Production by Type (2021-2032)
  9. 4.2.3 Global 3D Microfluidic Organ Chip Production Market Share by Type (2021-2032)
  10. 4.3 Global 3D Microfluidic Organ Chip Production Value by Type
  11. 4.3.1 Global 3D Microfluidic Organ Chip Production Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global 3D Microfluidic Organ Chip Production Value by Type (2021-2032)
  13. 4.3.3 Global 3D Microfluidic Organ Chip Production Value Market Share by Type (2021-2032)
5 3D Microfluidic Organ Chip Market by Application
  1. 5.1 3D Microfluidic Organ Chip Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Biotechnology
  4. 5.1.3 Others
  5. 5.2 Global 3D Microfluidic Organ Chip Production by Application
  6. 5.2.1 Global 3D Microfluidic Organ Chip Production by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global 3D Microfluidic Organ Chip Production by Application (2021-2032)
  8. 5.2.3 Global 3D Microfluidic Organ Chip Production Market Share by Application (2021-2032)
  9. 5.3 Global 3D Microfluidic Organ Chip Production Value by Application
  10. 5.3.1 Global 3D Microfluidic Organ Chip Production Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global 3D Microfluidic Organ Chip Production Value by Application (2021-2032)
  12. 5.3.3 Global 3D Microfluidic Organ Chip Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Emulate
  2. 6.1.1 Emulate Company Information
  3. 6.1.2 Emulate Business Overview
  4. 6.1.3 Emulate 3D Microfluidic Organ Chip Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Emulate 3D Microfluidic Organ Chip Product Portfolio
  6. 6.1.5 Emulate Recent Developments
  7. 6.2 TissUse
  8. 6.2.1 TissUse Company Information
  9. 6.2.2 TissUse Business Overview
  10. 6.2.3 TissUse 3D Microfluidic Organ Chip Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 TissUse 3D Microfluidic Organ Chip Product Portfolio
  12. 6.2.5 TissUse Recent Developments
  13. 6.3 Hesperos
  14. 6.3.1 Hesperos Company Information
  15. 6.3.2 Hesperos Business Overview
  16. 6.3.3 Hesperos 3D Microfluidic Organ Chip Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Hesperos 3D Microfluidic Organ Chip Product Portfolio
  18. 6.3.5 Hesperos Recent Developments
  19. 6.4 CN Bio Innovations
  20. 6.4.1 CN Bio Innovations Company Information
  21. 6.4.2 CN Bio Innovations Business Overview
  22. 6.4.3 CN Bio Innovations 3D Microfluidic Organ Chip Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 CN Bio Innovations 3D Microfluidic Organ Chip Product Portfolio
  24. 6.4.5 CN Bio Innovations Recent Developments
  25. 6.5 Tara Biosystems
  26. 6.5.1 Tara Biosystems Company Information
  27. 6.5.2 Tara Biosystems Business Overview
  28. 6.5.3 Tara Biosystems 3D Microfluidic Organ Chip Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Tara Biosystems 3D Microfluidic Organ Chip Product Portfolio
  30. 6.5.5 Tara Biosystems Recent Developments
  31. 6.6 Draper Laboratory
  32. 6.6.1 Draper Laboratory Company Information
  33. 6.6.2 Draper Laboratory Business Overview
  34. 6.6.3 Draper Laboratory 3D Microfluidic Organ Chip Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Draper Laboratory 3D Microfluidic Organ Chip Product Portfolio
  36. 6.6.5 Draper Laboratory Recent Developments
  37. 6.7 Mimetas
  38. 6.7.1 Mimetas Company Information
  39. 6.7.2 Mimetas Business Overview
  40. 6.7.3 Mimetas 3D Microfluidic Organ Chip Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Mimetas 3D Microfluidic Organ Chip Product Portfolio
  42. 6.7.5 Mimetas Recent Developments
  43. 6.8 Nortis
  44. 6.8.1 Nortis Company Information
  45. 6.8.2 Nortis Business Overview
  46. 6.8.3 Nortis 3D Microfluidic Organ Chip Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Nortis 3D Microfluidic Organ Chip Product Portfolio
  48. 6.8.5 Nortis Recent Developments
  49. 6.9 Micronit Microtechnologies B.V.
  50. 6.9.1 Micronit Microtechnologies B.V. Company Information
  51. 6.9.2 Micronit Microtechnologies B.V. Business Overview
  52. 6.9.3 Micronit Microtechnologies B.V. 3D Microfluidic Organ Chip Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Micronit Microtechnologies B.V. 3D Microfluidic Organ Chip Product Portfolio
  54. 6.9.5 Micronit Microtechnologies B.V. Recent Developments
  55. 6.10 Kirkstall
  56. 6.10.1 Kirkstall Company Information
  57. 6.10.2 Kirkstall Business Overview
  58. 6.10.3 Kirkstall 3D Microfluidic Organ Chip Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Kirkstall 3D Microfluidic Organ Chip Product Portfolio
  60. 6.10.5 Kirkstall Recent Developments
  61. 6.11 Cherry Biotech SAS
  62. 6.11.1 Cherry Biotech SAS Company Information
  63. 6.11.2 Cherry Biotech SAS Business Overview
  64. 6.11.3 Cherry Biotech SAS 3D Microfluidic Organ Chip Production, Value and Gross Margin (2021-2026)
  65. 6.11.4 Cherry Biotech SAS 3D Microfluidic Organ Chip Product Portfolio
  66. 6.11.5 Cherry Biotech SAS Recent Developments
  67. 6.12 Else Kooi Laboratory
  68. 6.12.1 Else Kooi Laboratory Company Information
  69. 6.12.2 Else Kooi Laboratory Business Overview
  70. 6.12.3 Else Kooi Laboratory 3D Microfluidic Organ Chip Production, Value and Gross Margin (2021-2026)
  71. 6.12.4 Else Kooi Laboratory 3D Microfluidic Organ Chip Product Portfolio
  72. 6.12.5 Else Kooi Laboratory Recent Developments
7 Global 3D Microfluidic Organ Chip Production by Region
  1. 7.1 Global 3D Microfluidic Organ Chip Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global 3D Microfluidic Organ Chip Production by Region (2021-2032)
  3. 7.2.1 Global 3D Microfluidic Organ Chip Production by Region (2021-2026)
  4. 7.2.2 Global 3D Microfluidic Organ Chip Production Forecast by Region (2027-2032)
  5. 7.3 Global 3D Microfluidic Organ Chip Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global 3D Microfluidic Organ Chip Production Value by Region (2021-2032)
  7. 7.4.1 Global 3D Microfluidic Organ Chip Production Value by Region (2021-2026)
  8. 7.4.2 Global 3D Microfluidic Organ Chip Production Value by Region (2027-2032)
  9. 7.5 Global 3D Microfluidic Organ Chip Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America 3D Microfluidic Organ Chip Production Value (2021-2032)
  12. 7.6.2 Europe 3D Microfluidic Organ Chip Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific 3D Microfluidic Organ Chip Production Value (2021-2032)
  14. 7.6.4 South America 3D Microfluidic Organ Chip Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa 3D Microfluidic Organ Chip Production Value (2021-2032)
8 Global 3D Microfluidic Organ Chip Consumption by Region
  1. 8.1 Global 3D Microfluidic Organ Chip Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global 3D Microfluidic Organ Chip Consumption by Region (2021-2032)
  3. 8.2.1 Global 3D Microfluidic Organ Chip Consumption by Region (2021-2026)
  4. 8.2.2 Global 3D Microfluidic Organ Chip Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America 3D Microfluidic Organ Chip Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe 3D Microfluidic Organ Chip Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific 3D Microfluidic Organ Chip Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America 3D Microfluidic Organ Chip Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa 3D Microfluidic Organ Chip Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 3D Microfluidic Organ Chip Value Chain Analysis
  2. 9.1.1 3D Microfluidic Organ Chip Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 3D Microfluidic Organ Chip Production Mode & Process
  6. 9.2 3D Microfluidic Organ Chip Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 3D Microfluidic Organ Chip Distributors
  9. 9.2.3 3D Microfluidic Organ Chip Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst